跳至主要内容
临床试验/NCT00969163
NCT00969163已完成1 期

A Pilot Study to Investigate Biomarkers of Skin Androgenization Following Short-Term Testosterone Administration in Healthy Postmenopausal Women

Merck Sharp & Dohme LLC0 个研究点目标入组 30 人开始时间: 2004年10月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
30
主要终点
serum free testosterone concentrations following multiple doses of AndroGel

研究概览

简要总结

Postmenopausal women will receive testosterone gel or matching placebo gel daily. Sebum excretion rates will be measured before and after 6 weeks of treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double (Participant, Investigator)

入排标准

年龄范围
50 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Subject is at least 3 years postmenopausal
  • Subject is in good general health
  • Subject is willing to avoid excess alcohol or strenuous physical activity during the study

排除标准

  • Subject has donated a unit of blood or has taken an investigational drug in another clinical trial in the last 4 weeks
  • Subject is a regular user of any illicit drugs
  • Subject drinks excessive amounts of coffee, tea or cola
  • Subject has used an estrogen or progestogens hormone replacement therapy in the past 6 months
  • Subject has a history of cancer
  • Subject has acne

研究组 & 干预措施

1

Experimental

2.5 mg testosterone gel

干预措施: testosterone gel (Drug)

2

Experimental

300 ug testosterone gel

干预措施: testosterone gel (Drug)

结局指标

主要结局

serum free testosterone concentrations following multiple doses of AndroGel

时间窗: 6 weeks

次要结局

  • mean percent change from baseline in sebum excretion(6 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验